Insights

Innovative Therapeutics Seed Therapeutics specializes in developing molecular glue degraders targeting traditionally undruggable disease drivers, which presents an opportunity to offer advanced drug delivery and formulation solutions to accelerate their clinical pipeline.

Funding Momentum With a recent Series A3 financing of 30 million dollars and FDA IND approval for their lead program, the company is poised for rapid growth and potential procurement of specialized research and development services or strategic partnerships.

Strategic Collaborations Their ongoing partnerships with academic and industry experts, along with development collaborations like Eisai, suggest opportunities for companies providing biotechnological tools, research platforms, or contract research services tailored to targeted protein degradation.

Recognition and Growth Being a finalist at the 2025 Prix Galien USA

Market Expansion Focused on neurodegeneration and oncology, Seed Therapeutics is expanding its pipeline in these high-demand therapeutic areas, providing opportunities for pharma and biotech providers interested in partnering on novel treatments for major markets.

Seed Therapeutics Tech Stack

Seed Therapeutics uses 8 technology products and services including LiteSpeed Cache, RSS, Font Awesome, and more. Explore Seed Therapeutics's tech stack below.

LiteSpeed Cache

Caching

RSS

Content Management System

Font Awesome

Font Scripts

Pantheon

Platform As A Service

PHP

Programming Languages

YouTube

Video Players

a3 Lazy Load

Web Platform Extensions

Magnific Popup

Web Tools And Plugins

Seed Therapeutics Email Formats	Example	Percentage
First.Last@seedtherapeutics.com	John.Doe@seedtherapeutics.com	50%
First.Last@seedtherapeutics.com	John.Doe@seedtherapeutics.com	50%

Seed Therapeutics Email Formats

Example

Percentage

First.Last@seedtherapeutics.com

John.Doe@seedtherapeutics.com

50%

First.Last@seedtherapeutics.com

John.Doe@seedtherapeutics.com

50%

Frequently Asked Questions

Where is Seed Therapeutics's headquarters located?

Seed Therapeutics's main headquarters is located at 28 Liberty Street 39th Floor New York, New York 10005 United States. The company has employees across 1 continents, including North America.

What is Seed Therapeutics's official website and social media links?

Seed Therapeutics's official website is seedtherapeutics.com and has social profiles on LinkedIn Crunchbase.

What is Seed Therapeutics's SIC code NAICS code?

Seed Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Seed Therapeutics have currently?

As of March 2026, Seed Therapeutics has approximately 24 employees across 1 continents, including North America. Key team members include Chief Financial Officer/Chief Business Officer: B. D.President And Chief Scientific Officer: J. T.Co-Founder, Chairman & Ceo: L. H.. Explore Seed Therapeutics's employee directory with LeadIQ.

What industry does Seed Therapeutics belong to?

Seed Therapeutics operates in the Biotechnology Research industry.

What technology does Seed Therapeutics use?

Seed Therapeutics's tech stack includes LiteSpeed CacheRSSFont AwesomePantheonPHPYouTubea3 Lazy LoadMagnific Popup.

What is Seed Therapeutics's email format?

Seed Therapeutics's email format typically follows the pattern of First.Last@seedtherapeutics.com. Find more Seed Therapeutics email formats with LeadIQ.

How much funding has Seed Therapeutics raised to date?

As of March 2026, Seed Therapeutics has raised $30M in funding. The last funding round occurred on Aug 06, 2024 for $30M.

Seed Therapeutics

Q: How many employees does Seed Therapeutics have currently?

Seed Therapeutics has approximately 24 employees.

Q: What technology does Seed Therapeutics use?

Seed Therapeutics's tech stack includes LiteSpeed Cache, Varnish, Priority Hints, Divi, HTTP/3.

Biotechnology ResearchNew York, United States11-50 Employees

Seed Therapeutics is pioneering the science of improving human health by creating “molecular glues”: novel therapeutics that degrade disease-causing proteins that have heretofore remained “undruggable.”

Through ongoing collaborations with world-leading academic experts in the field, and in partnership with seasoned drug development and commercialization experts, Seed Therapeutics is establishing a growing pipeline of exciting drug candidates on a path to clinical and commercial success.

Our mission is to positively impact human health by creating novel protein degradation therapeutics for the treatment of severe diseases for which health care professionals currently have limited options to offer to patients.

Insights

Similar companies to Seed Therapeutics

Pivot Bio

AgBiome

AgBiTech

Joyn Bio

Benson Hill

NovoNutrients

Indigo Agriculture